Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

14.02
-0.3600-2.50%
Post-market: 14.020.00000.00%19:30 EDT
Volume:669.50K
Turnover:9.44M
Market Cap:1.18B
PE:17.93
High:14.55
Open:14.42
Low:13.93
Close:14.38
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:1.06
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.16
PE(LYR):42.48

Loading ...

Bioventus Q1 Adjusted Ebitda USD 23.9 Million

THOMSON REUTERS
·
May 06

Bioventus Inc: Reaffirms Revenue Guidance for 2026

THOMSON REUTERS
·
May 06

Bioventus Q1 Adjusted EPS USD 0.15 VS. Ibes Estimate USD 0.1

THOMSON REUTERS
·
May 06

Press Release: Bioventus Reports First Quarter Financial Results

Dow Jones
·
May 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

Top News Today: Stocks Rise, Oil Falls, as War Restart Fears Subside

Dow Jones
·
May 06

Bioventus Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
May 04

TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln

THOMSON REUTERS
·
May 01

TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair

THOMSON REUTERS
·
May 01

TELA Bio Inc - Chairman Doug Evans, Kurt Azarbarzin, Vince Burgess, Federica O’brien to Depart Board

THOMSON REUTERS
·
May 01

Bioventus to report fiscal Q1 results, host conference call

Reuters
·
Apr 29

Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

GlobeNewswire
·
Apr 29

Bioventus announces annual shareholder meeting

Reuters
·
Apr 22

Bravura Issues 1.6 Million Unquoted Options Under Employee Incentive Plan

TIPRANKS
·
Apr 22

Bravura Solutions Flags Conversion of Unquoted Equity Securities

TIPRANKS
·
Apr 02

Bravura Solutions Reshapes Governance Team With New Joint Company Secretaries

TIPRANKS
·
Apr 02

Bioventus initiated with an Outperform at CJS Securities

TIPRANKS
·
Mar 27

Bioventus Inc. publishes corporate presentation on musculoskeletal pain and surgical solutions portfolio with USD 568 million 2025 revenue

Reuters
·
Mar 17

Bravura Resets CEO Sign-On Option Price to Reflect Market Levels

TIPRANKS
·
Mar 16

Bioventus Director Michelle McMurry-Heath Disposes of Common Shares

Reuters
·
Mar 14